Evidence map›Paper›PMID 28512736›Full record

ArticleHuman mutation2017

CAGI4 SickKids clinical genomes challenge: A pipeline for identifying pathogenic variants.

Lipika R Pal, Kunal Kundu, Yizhou Yin, John Moult

Abstract read
In one paragraph

Article in Human mutation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Analysis and Interpretation of the Impact of Missense Variants in Cancer.International journal of molecular sciences · 2021
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lipika R PalInstitute for Bioscience and Biotechnology Research, University of Maryland, Rockville, Maryland.
Kunal KunduInstitute for Bioscience and Biotechnology Research, University of Maryland, Rockville, Maryland.
Yizhou YinInstitute for Bioscience and Biotechnology Research, University of Maryland, Rockville, Maryland.
John MoultInstitute for Bioscience and Biotechnology Research, University of Maryland, Rockville, Maryland.ORCID 0000-0002-3012-2282

Funding

Component 2 - Resource ProjectU41HG007346 · NHGRI · UNIVERSITY OF CALIFORNIA BERKELEY · PI BRENNER, STEVEN E · 2015 to 2017
$1.7M
Mechanisms underlying complex trait human diseaseR01GM104436 · NIGMS · UNIV OF MARYLAND, COLLEGE PARK · PI MOULT, JOHN · 2013 to 2016
$1.1M
Molecular impact of mutations in monogenic disease and cancerR01GM120364 · NIGMS · UNIV OF MARYLAND, COLLEGE PARK · PI MOULT, JOHN · 2016 to 2018
$1.1M
Critical Assessment of Genome Interpretation ConferenceR13HG006650 · NHGRI · UNIVERSITY OF CALIFORNIA BERKELEY · PI BRENNER, STEVEN E · 2011 to 2018
$165k
NHGRI NIH HHS R13 HG006650NHGRI NIH HHS U41 HG007346NIGMS NIH HHS R01 GM104436NIGMS NIH HHS R01 GM120364
6 · The paper itself

Abstract

Compared with earlier more restricted sequencing technologies, identification of rare disease variants using whole-genome sequence has the possibility of finding all causative variants, but issues of data quality and an overwhelming level of background variants complicate the analysis. The CAGI4 SickKids clinical genome challenge provided an opportunity to assess the landscape of variants found in a difficult set of 25 unsolved rare disease cases. To address the challenge, we developed a three-stage pipeline, first carefully analyzing data quality, then classifying high-quality gene-specific variants into seven categories, and finally examining each candidate variant for compatibility with the often complex phenotypes of these patients for final prioritization. Variants consistent with the phenotypes were found in 24 out of the 25 cases, and in a number of these, there are prioritized variants in multiple genes. Data quality analysis suggests that some of the selected variants are likely incorrect calls, complicating interpretation. The data providers followed up on three suggested variants with Sanger sequencing, and in one case, a prioritized variant was confirmed as likely causative by the referring physician, providing a diagnosis in a previously intractable case.

Indexed as

Genetic VariationChildGenetic Predisposition to DiseaseGenomicsHumansRare DiseasesSequence Analysis, DNASoftwareCAGIComplete Genomics datadiagnostic variantsHuman Phenotype Ontology (HPO)pediatric rare diseaseswhole-genome sequencing data

Identifiers

PMID28512736
PMCPMC5577808

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.